Phosphorothioates, Essential Components of Therapeutic Oligonucleotides

Untitled work

Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714 · see citing works

The nature of the chemical bond—1992

Pauling, L. C. (1992) · Journal of Chemical Education · doi:10.1021/ed069p519 · Cited by 13,232 · see citing works

CpG motifs in bacterial DNA trigger direct B-cell activation

Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508 · see citing works

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082 · see citing works

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792 · see citing works

A Sequencing Method Based on Real-Time Pyrophosphate

Ronaghi, M., Uhlén, M., & Nyrén, P. (1998) · Science · doi:10.1126/science.281.5375.363 · Cited by 1,630 · see citing works

LNA-mediated microRNA silencing in non-human primates

Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · see citing works

RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform

Bennett, C. F., & Swayze, E. E. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,381 · see citing works

A general two-metal-ion mechanism for catalytic RNA

Steitz, T. A., & Steitz, J. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6498 · Cited by 1,171 · see citing works

Conserved Function of lincRNAs in Vertebrate Embryonic Development despite Rapid Sequence Evolution

Ulitsky, I., Shkumatava, A., Jan, C. H., Sive, H. L., & Bartel, D. P. (2011) · Cell · doi:10.1016/j.cell.2011.11.055 · Cited by 1,162 · see citing works

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152 · see citing works

Acids and Bases

Pearson, R. G. (1966) · Science · doi:10.1126/science.151.3707.172 · Cited by 1,009 · see citing works

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M., Cromwell, W. C., Lachmann, R., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 921 · see citing works

NUCLEOSIDE PHOSPHOROTHIOATES

Eckstein, F. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.002055 · Cited by 849 · see citing works

Evaluation of 2‘-modified oligonucleotides containing 2‘-deoxy gaps as antisense inhibitors of gene expression

Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D. P. C., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., & Freier, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85268-7 · Cited by 779 · see citing works

Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

Goemans, N., Tulinius, M., van den Akker, J. T., Burm, B. E. A., Ekhart, P. F., Heuvelmans, N., Holling, T. M., Janson, A. A. M., Platenburg, G. J., Sipkens, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011367 · Cited by 678 · see citing works

Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation

Modarresi, F., Faghihi, M. A., López-Toledano, M. A., Fatemi, R. P., Magistri, M., Brothers, S. P., van der Brug, M. P., & Wahlestedt, C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2158 · Cited by 668 · see citing works

Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse modelPreprint

Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R. (2010) · Genes & Development · doi:10.1101/gad.1941310 · Cited by 665 · see citing works

Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice

Prakash, T. P., Graham, M. J., Yu, J., Carty, R., Low, A., Chappell, A. E., Schmidt, K., Zhao, C., Aghajan, M., Murray, H. F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku531 · Cited by 616 · see citing works

A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioningPreprint

Valouev, A., Ichikawa, J. K., Tonthat, T., Stuart, J., Ranade, S., Peckham, H. E., Zeng, K., Malek, J. A., Costa, G. L., McKernan, K. J., et al. (2008) · Genome Research · doi:10.1101/gr.076463.108 · Cited by 580 · see citing works

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

Matsukura, M., Shinozuka, K., Zon, G., Mitsuya, H., Reitz, M. S., Cohen, J. S., & Broder, S. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7706 · Cited by 533 · see citing works

Specificity, duplex degradation and subcellular localization of antagomirs

Krützfeldt, J., Kuwajima, S., Braich, R. S., Rajeev, K. G., Pena, J., Tuschl, T., Manoharan, M., & Stoffel, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm024 · Cited by 456 · see citing works

Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.

Walder, R. Y., & Walder, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5011 · Cited by 453 · see citing works

Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents

Stein, C. A., Hansen, J. B., Lai, J. C. H., Wu, S., Voskresenskiy, A. M., H⊘g, A., Worm, J., Hedtjärn, M., Souleimanian, N. E., Miller, P. S., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp841 · Cited by 384 · see citing works

Regulation of Gene Expression with Double-Stranded Phosphorothioate Oligonucleotides

Bielinska, A. U., Shivdasani, R. A., Zhang, L., & Nabel, G. J. (1990) · Science · doi:10.1126/science.2237444 · Cited by 372 · see citing works

RNA catalyses nuclear pre-mRNA splicing

Fica, S. M., Tuttle, N., Novak, T., Li, N., Lu, J., Koodathingal, P., Dai, Q., Staley, J. P., & Piccirilli, J. A. (2013) · Nature · doi:10.1038/nature12734 · Cited by 348 · see citing works

A semisynthetic epitope for kinase substrates

Allen, J. J., Li, M., Brinkworth, C. S., Paulson, J., Wang, D., Hübner, A., Chou, W.-H., Davis, R. J., Burlingame, A. L., Messing, R. O., et al. (2007) · Nature Methods · doi:10.1038/nmeth1048 · Cited by 330 · see citing works

MODIFIED OLIGONUCLEOTIDES: Synthesis and Strategy for Users

Verma, S. K., & Eckstein, F. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.99 · Cited by 315 · see citing works

Stability constants of magnesium and cadmium complexes of adenine nucleotides and thionucleotides and rate constants for formation and dissociation of magnesium-ATP and magnesium-ADP

Pecoraro, V. L., Hermes, J. D., & Cleland, W. W. (1984) · Biochemistry · doi:10.1021/bi00317a026 · Cited by 291 · see citing works

Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

Agrawal, S., Goodchild, J., Civeira, M. P., Thornton, A., Sarin, P. S., & Zamecnik, P. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7079 · Cited by 291 · see citing works

Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats

Geary, R. S., Watanabe, T. A., Truong, L., Freier, S., Lesnik, E. A., Sioufi, N. B., Sasmor, H. M., Manoharan, M., & Levin, A. A. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38831-7 · Cited by 289 · see citing works

Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes

Koller, E., Vincent, T. M., Chappell, A. E., De, S., Manoharan, M., & Bennett, C. F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr089 · Cited by 284 · see citing works

Bond Order and Charge Localization in Nucleoside Phosphorothioates

Frey, P. A., & Sammons, R. D. (1985) · Science · doi:10.1126/science.2984773 · Cited by 281 · see citing works

Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression

Yu, D., Pendergraff, H. M., Liu, J., Kordasiewicz, H. B., Cleveland, D. W., Swayze, E. E., Lima, W. F., Crooke, S. T., Prakash, T. P., & Corey, D. R. (2012) · Cell · doi:10.1016/j.cell.2012.08.002 · Cited by 277 · see citing works

The Role of Environmental Carcinogens, Viruses, and Genetic

Powers, A. A., & Carbone, M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.4 · Cited by 276 · see citing works

Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotides

Stec, W. J., Zon, G., & Egan, W. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00332a054 · Cited by 276 · see citing works

Phosphorothioation of DNA in bacteria by dnd genes

Wang, L., Chen, S., Xu, T., Taghizadeh, K., Wishnok, J. S., Zhou, X., You, D., Deng, Z., & Dedon, P. C. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.39 · Cited by 274 · see citing works

Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.

Matsukura, M., Zon, G., Shinozuka, K., Robert-Guroff, M., Shimada, T., Stein, C. A., Mitsuya, H., Wong‐Staal, F., Cohen, J. S., & Broder, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4244 · Cited by 262 · see citing works

Single-Stranded siRNAs Activate RNAi in Animals

Lima, W. F., Prakash, T. P., Murray, H. M., Kinberger, G. A., Li, W., Chappell, A. E., Li, C., Murray, S., Gaus, H. J., Seth, P. P., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.014 · Cited by 256 · see citing works

The use of phosphorothioate-modified DNA in restriction enzyme reactions to prepare nicked DNA

Taylor, J. W., SCHMIDT, W. A., Cosstick, R., Okruszek, A., & Eckstein, F. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.24.8749 · Cited by 245 · see citing works

Fomivirsen

Perry, C. M., & Balfour, J. A. B. (1999) · Drugs · doi:10.2165/00003495-199957030-00010 · Cited by 243 · see citing works

DNA and RNA Sequence Determination Based on Phosphorothioate Chemistry

Gish, G. D., & Eckstein, F. (1988) · Science · doi:10.1126/science.2453926 · Cited by 232 · see citing works

Synthesis, Properties, and Applications of Oligonucleotides Containing an RNA Dinucleotide Phosphorothiolate Linkage

Li, N., Frederiksen, J. K., & Piccirilli, J. A. (2011) · Accounts of Chemical Research · doi:10.1021/ar200131t · Cited by 225 · see citing works

Structural principles for the inhibition of the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I by phosphorothioates

Brautigam, C. A., & Steitz, T. A. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1586 · Cited by 205 · see citing works

Adenosine 5′-0(3-thiotriphosphate) in the control of phosphorytase activity

Gratecos, D., & Fischer, E. H. (1974) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(74)80237-8 · Cited by 190 · see citing works

CpG Still Rocks! Update on an Accidental Drug

Krieg, A. Μ. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0340 · Cited by 184 · see citing works

Thiophosphate analogs of nucleoside di- and triphosphates

Goody, R. S., & Eckstein, F. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00752a042 · Cited by 181 · see citing works

Antisense Drug Technology

(2007) · CRC Press eBooks · doi:10.1201/9780849387951 · Cited by 181 · see citing works

RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds

Furdon, P. J., Domiński, Z., & Kole, R. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.22.9193 · Cited by 178 · see citing works

A study of the mechanism of DNA polymerase I from Escherichia coli with diastereomeric phosphorothioate analogs of deoxyadenosine triphosphate.

Burgers, P., & Eckstein, F. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50258-1 · Cited by 176 · see citing works

Mapping the active site of ribonuclease P RNA using a substrate containing a photoaffinity agent.

Burgin, A. B., & Pace, N. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07633.x · Cited by 175 · see citing works

Absolute configuration of the diastereomers of adenosine 5'-O-(1-thiotriphosphate): consequences for the stereochemistry of polymerization by DNA-dependent RNA polymerase from Escherichia coli.

Burgers, P., & Eckstein, F. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4798 · Cited by 169 · see citing works

Synthesis and configurational analysis of a dinucleoside phosphate isotopically chiral at phosphorus. Stereochemical course of Penicillium citrinum nuclease P1 reaction

Potter, B. V. L., Connolly, B. A., & Eckstein, F. (1983) · Biochemistry · doi:10.1021/bi00275a008 · Cited by 166 · see citing works

Synthesis and characterization of an octanucleotide containing the EcoRI recognition sequence with a phosphorothioate group at the cleavage site

Connolly, B. A., Potter, B. V. L., Eckstein, F., Pingoud, A. M., & Grotjahn, L. (1984) · Biochemistry · doi:10.1021/bi00310a010 · Cited by 159 · see citing works

Divalent cation-dependent stereospecificity of adenosine 5‘-O-(2-thiotriphosphate) in the hexokinase and pyruvate kinase reactions. The absolute stereochemistry of the diastereoisomers of adenosine 5‘-O-(2-thiotriphosphate).

Jaffe, E. K., & Cohn, M. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34617-3 · Cited by 149 · see citing works

Inhibition of deoxyribonucleases by phosphorothioate groups in oligodeoxyribonucleotides

Spitzer, S. G., & Eckstein, F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.24.11691 · Cited by 143 · see citing works

Geometry of the First Step in the Action of Ribonuclease-A

Usher, D. A., Erenrich, E. S., & Eckstein, F. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.1.115 · Cited by 140 · see citing works

Interferon Induction Increased through Chemical Modification of a Synthetic Polyribonucleotide

Clercq, E. D., Eckstein, F., & Merigan, T. C. (1969) · Science · doi:10.1126/science.165.3898.1137 · Cited by 135 · see citing works

A novel host-specific restriction system associated with DNA backbone S-modification in Salmonella

Xu, T., Yao, F., Zhou, X., Deng, Z., & You, D. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq610 · Cited by 134 · see citing works

Absolute Stereochemistry of the Second Step of Ribonuclease Action

Usher, D. A., Richardson, D. I., & Eckstein, F. (1970) · Nature · doi:10.1038/228663a0 · Cited by 132 · see citing works

Cellular Uptake and Intracellular Trafficking of Oligonucleotides: Implications for Oligonucleotide Pharmacology

Juliano, R. L., Ming, X., Carver, K. A., & Laing, B. M. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0463 · Cited by 130 · see citing works

Stereospecificity of nucleases towards phosphorothioate-substituted RNA: stereochemistry of transcription by T7 RNA polymerase

Griffiths, A. D., POTTER, B. V. L., & Eperon, I. C. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.10.4145 · Cited by 127 · see citing works

Characterization of Target mRNA Reduction Through In Situ RNA Hybridization in Multiple Organ Systems Following Systemic Antisense Treatment in Animals

Hung, G., Xiao, X., Peralta, R. Q., Bhattacharjee, G., Murray, S., Norris, D., Guo, S., & Monia, B. P. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0443 · Cited by 126 · see citing works

Solid-Phase Synthesis of Stereoregular Oligodeoxyribonucleoside Phosphorothioates Using Bicyclic Oxazaphospholidine Derivatives as Monomer Units

Oka, N., Yamamoto, M., Sato, T., & Wada, T. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805780u · Cited by 123 · see citing works

Chiral phosphorothioate analogues of B-DNA

Cruse, W. B. T., Salisbury, S. A., Brown, T., Cosstick, R., Eckstein, F., & Kennard, O. (1986) · Journal of Molecular Biology · doi:10.1016/0022-2836(86)90035-5 · Cited by 123 · see citing works

Deoxyribonucleoside 3‘- O -(2-Thio- and 2-Oxo-“spiro”-4,4-pentamethylene-1,3,2-oxathiaphospholane)s: Monomers for Stereocontrolled Synthesis of Oligo(deoxyribonucleoside phosphorothioate)s and Chimeric PS/PO Oligonucleotides

Stec, W. J., Karwowski, B. T., Boczkowska, M., Guga, P., Koziołkiewicz, M., Sochacki, M., Wieczorek, M. W., & Błaszczyk, J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973801j · Cited by 122 · see citing works

Phosphorothioate primers improve the amplification of DNA sequences by DNA polymerases with proofreading activity

Skerra, A. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.14.3551 · Cited by 118 · see citing works

Nucleoside Phosphorothioates

Eckstein, F. (1966) · Journal of the American Chemical Society · doi:10.1021/ja00970a054 · Cited by 116 · see citing works

Stereodifferentiation—the effect of P chirality of oligo (nucleoside phosphorothioates) on the activity of bacterial RNase H

Koziołkiewicz, M., Krakowiak, A., Kwinkowski, M., Boczkowska, M., & Stec, W. J. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5000 · Cited by 111 · see citing works

Chemical Modification Study of Antisense Gapmers

Stanton, R. V., Sciabola, S., Salatto, C. T., Weng, Y., Moshinsky, D., Little, J., Walters, E., Kreeger, J. M., DiMattia, D. A., Chen, T. X., et al. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0366 · Cited by 110 · see citing works

Genomic mapping of phosphorothioates reveals partial modification of short consensus sequences

Cao, B., Chen, C., DeMott, M. S., Cheng, Q., Clark, T. A., Xiong, X., Zheng, X., Butty, V. L., Levine, S. S., Yuan, G., et al. (2014) · Nature Communications · doi:10.1038/ncomms4951 · Cited by 107 · see citing works

TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo

Zhang, Q., Hossain, D. M. S., Nechaev, S., Kozłowska, A. K., Zhang, W., Liu, Y., Kowolik, C. M., Swiderski, P. M., Rossi, J. J., Forman, S. J., et al. (2013) · Blood · doi:10.1182/blood-2012-07-442590 · Cited by 107 · see citing works

Defining the chemical groups essential for Tetrahymena group I intron function by nucleotide analog interference mapping

Strobel, S. A., & Shetty, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2903 · Cited by 107 · see citing works

Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing

Rigo, F., Hua, Y., Chun, S. J., Prakash, T. P., Krainer, A. R., & Bennett, C. F. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.939 · Cited by 102 · see citing works

Deoxynucleoside [1-thio]triphosphates prevent proofreading during in vitro DNA synthesis.

Kunkel, T. A., Eckstein, F., Mildvan, A. S., Koplitz, R. M., & Loeb, L. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6734 · Cited by 102 · see citing works

A Chemical View of Oligonucleotides for Exon Skipping and Related Drug Applications

Järver, P., O’Donovan, L., & Gait, M. J. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0454 · Cited by 100 · see citing works

Stereochemistry of a substrate for pancreatic ribonuclease. Crystal and molecular structure of the triethylammonium salt of uridine 2', 3'-0,0-cyclophosphorothioate

Saenger, W., & Eckstein, F. (1970) · Journal of the American Chemical Society · doi:10.1021/ja00718a038 · Cited by 98 · see citing works

Movement of the Guide Sequence During RNA Catalysis by a Group I Ribozyme

Wang, J., Downs, W. D., & Cech, T. R. (1993) · Science · doi:10.1126/science.7682726 · Cited by 97 · see citing works

Antisense Oligonucleotides for the Treatment of Spinal Muscular Atrophy

Porensky, P. N., & Burghes, A. H. M. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.225 · Cited by 89 · see citing works

Stereodefined Phosphorothioate Analogues of DNA: Relative Thermodynamic Stability of the Model PS-DNA/DNA and PS-DNA/RNA Complexes

Boczkowska, M., Guga, P., & Stec, W. J. (2002) · Biochemistry · doi:10.1021/bi026225z · Cited by 88 · see citing works

A study of the mechanism of T4 DNA polymerase with diastereomeric phosphorothioate analogues of deoxyadenosine triphosphate.

Romaniuk, P. J., & Eckstein, F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34435-1 · Cited by 86 · see citing works

Phosphorothioate DNA as an antioxidant in bacteria

Xie, X., Liang, J., Pu, T., Xu, F., Yao, F., Yang, Y., Zhao, Y., You, D., Zhou, X., Deng, Z., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks650 · Cited by 81 · see citing works

Direct sequencing of polymerase chain reaction amplified DNA fragments through the incorporation of deoxynucleoside α-thiotriphosphates

Nakamaye, K. L., Gish, G. D., Eckstein, F., & Vosberg, H.-P. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.21.9947 · Cited by 79 · see citing works

Antisense 2′-Deoxy, 2′-Fluoroarabino Nucleic Acid (2′F-ANA) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids

Souleimanian, N. E., Deleavey, G. F., Soifer, H. S., Wang, S., Tiemann, K., Damha, M. J., & Stein, C. A. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.35 · Cited by 71 · see citing works

Potent Gene-Specific Inhibitory Properties of Mixed-Backbone Antisense Oligonucleotides Comprised of 2‘-Deoxy-2‘-fluoro- d -arabinose and 2‘-Deoxyribose Nucleotides,

Lok, C., Viazovkina, E., Min, K., Nagy, E., Wilds, C. J., Damha, M. J., & Parniak, M. A. (2002) · Biochemistry · doi:10.1021/bi0115075 · Cited by 70 · see citing works

Development of Therapeutic Splice-Switching Oligonucleotides

Disterer, P., Kryczka, A., Liu, Y., Badi, Y. E., Wong, J. J., Owen, J. S., & Khoo, B. C. E. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.234 · Cited by 69 · see citing works

Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9

Kandimalla, E. R., Bhagat, L., Wang, D., Yu, D. S., Sullivan, T., Monica, N. L., & Agrawal, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt078 · Cited by 69 · see citing works

Oligonucleotide N3′→P5′ Phosphoramidates and Thio‐Phoshoramidates as Potential Therapeutic Agents

Gryaznov, S. M. (2010) · Chemistry & Biodiversity · doi:10.1002/cbdv.200900187 · Cited by 68 · see citing works

Synthesis of dinucleoside monophosphorothioates via addition of sulphur to phosphite triesters.

Burgers, P., & Eckstein, F. (1978) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)95072-5 · Cited by 62 · see citing works

Fluorescent labelling of tRNA and oligodeoxynucleotides using T4 RNA ligase

Cosstick, R., McLaughlin, L. W., & Eckstein, F. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.4.1791 · Cited by 61 · see citing works

Impaired Transition State Complementarity in the Hydrolysis of O-Arylphosphorothioates by Protein-Tyrosine Phosphatases

Zhang, Y., Hollfelder, F., Gordon, S. J., Chen, L., Keng, Y., Wu, L., Herschlag, D., & Zhang, Z. (1999) · Biochemistry · doi:10.1021/bi990836i · Cited by 59 · see citing works

Stereochemical course of polymerization catalyzed by avian myeloblastosis virus reverse transcriptase.

Bartlett, P. A., & Eckstein, F. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34212-1 · Cited by 59 · see citing works

Peptide Conjugation of 2′- O -methyl Phosphorothioate Antisense Oligonucleotides Enhances Cardiac Uptake and Exon Skipping in mdx Mice

Jirka, S. M. G., Heemskerk, H., Winter, C. L. T.-D., Muilwijk, D., Pang, K. H., de Visser, P. C., Janson, A. A. M., Karnaoukh, T. G., Vermue, R., Hoen, P. A. C. ’., et al. (2013) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0448 · Cited by 58 · see citing works

The antiviral activity of thiophosphate-substituted polyribonucleotides in vitro and in vivo

Clercq, E. D., Eckstein, F., Sternbach, H., & Merigan, T. C. (1970) · Virology · doi:10.1016/0042-6822(70)90285-0 · Cited by 57 · see citing works

Sulfur does not form double bonds in phosphorothioate anions

Liang, C., & Allen, L. C. (1987) · Journal of the American Chemical Society · doi:10.1021/ja00255a034 · Cited by 55 · see citing works

Stereochemical course of DNA hydrolysis by nuclease S1.

Potter, B. V. L., Romaniuk, P. J., & Eckstein, F. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33051-5 · Cited by 54 · see citing works

Phosphorothioate-containing RNAs show mRNA activity in the prokaryotic translation systemsin vitro

Ueda, T., Tohda, H., Chikazumi, N., Eckstein, F., & Watanabe, K. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.3.547 · Cited by 52 · see citing works

P-Chirality-Dependent Immune Activation by Phosphorothioate CpG Oligodeoxynucleotides

Krieg, A. Μ., Guga, P., & Stec, W. J. (2003) · Oligonucleotides · doi:10.1089/154545703322860807 · Cited by 51 · see citing works

Pathological phenotypes and in vivo DNA cleavage by unrestrained activity of a phosphorothioate‐based restriction system in S almonella

Cao, B., Cheng, Q., Gu, C., Yao, F., DeMott, M. S., Zheng, X., Deng, Z., Dedon, P. C., & You, D. (2014) · Molecular Microbiology · doi:10.1111/mmi.12692 · Cited by 49 · see citing works

Stereodependent Inhibition of Plasminogen Activator Inhibitor Type 1 by Phosphorothioate Oligonucleotides: Proof of Sequence Specificity in Cell Culture and In Vivo Rat Experiments

Stec, W. J., Cierniewski, C. S., Okruszek, A., Kobylańska, A., Pawłowska, Z., Koziołkiewicz, M., Pluskota, E., Maciaszek, A. D., Rębowska, B., & Stasiak, M. (1997) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1997.7.567 · Cited by 45 · see citing works

ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy

Liu, J., Yu, D., Aiba, Y., Pendergraff, H. M., Swayze, E. E., Lima, W. F., Hu, J., Prakash, T. P., & Corey, D. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt693 · Cited by 42 · see citing works

Acceptor Helix Interactions in a Class II tRNA Synthetase: Photoaffinity Crosslinking of an RNA Miniduplex Substrate

Musier‐Forsyth, K., & SCHIMMEL, P. R. (1994) · Biochemistry · doi:10.1021/bi00169a019 · Cited by 42 · see citing works

A Polyribonucleotide Containing Alternating → P = O and → P = S Linkages

Matzura, H., & Eckstein, F. (1968) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1967.tb19551.x · Cited by 41 · see citing works

Metal-ion rescue revisited: Biochemical detection of site-bound metal ions important for RNA folding

Frederiksen, J. K., Li, N., Das, R., Herschlag, D., & Piccirilli, J. A. (2012) · RNA · doi:10.1261/rna.028738.111 · Cited by 40 · see citing works

Incorporation of phosphorothioate groups into fd and φX174 DNA

Vosberg, H.-P., & Eckstein, F. (1977) · Biochemistry · doi:10.1021/bi00635a020 · Cited by 38 · see citing works

Allele-Selective Inhibition of Mutant Atrophin-1 Expression by Duplex and Single-Stranded RNAs

Hu, J., Liu, J., Jayaprakash, K. N., Lackey, J. G., Kuchimanchi, S., Rajeev, K. G., Manoharan, M., Swayze, E. E., Lima, W. F., Prakash, T. P., et al. (2014) · Biochemistry · doi:10.1021/bi500610r · Cited by 35 · see citing works

Target mRNA inhibition by oligonucleotide drugs in man

Lightfoot, H. L., & Hall, J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks861 · Cited by 34 · see citing works

Effect of ion pairing on bond order and charge localization in alkyl phosphorothioates

Baraniak, J., & Frey, P. A. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00220a067 · Cited by 34 · see citing works

Uridin‐2′.3′‐O.O‐cyclothiophosphat

Eckstein, F., & Gindl, H. (1968) · Chemische Berichte · doi:10.1002/cber.19681010518 · Cited by 33 · see citing works

Fomiversen Sodium Approved to Treat CMV Retinitis

Piascik, P. (1999) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30428-4 · Cited by 32 · see citing works

Phosphorus-oxygen bond order in adenosine 5'-O-phosphorothioate dianion

Iyengar, R., Eckstein, F., & Frey, P. A. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00338a059 · Cited by 31 · see citing works

Thiol-ene Enabled Detection of Thiophosphorylated Kinase Substrates

Garber, K. C. A., & Carlson, E. E. (2013) · ACS Chemical Biology · doi:10.1021/cb400184v · Cited by 27 · see citing works

Thiophosphorylated Substrate Analogs Are Potent Active Site-Directed Inhibitors of Protein-Tyrosine Phosphatases

Hiriyanna, K. T., Baedke, D. S., Baek, K., Forney, B. A., Kordiyak, G. J., & Ingebritsen, T. S. (1994) · Analytical Biochemistry · doi:10.1006/abio.1994.1545 · Cited by 26 · see citing works

Polyribonucleotides containing a thiophosphate backbone

Eckstein, F., & Gindl, H. (1969) · FEBS Letters · doi:10.1016/0014-5793(69)80037-2 · Cited by 26 · see citing works

Modification of Decoy Oligodeoxynucleotides to Achieve the Stability and Therapeutic Efficacy

Osako, M. K., Hironori Nakagami, A., & Morishita, R. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612803531397 · Cited by 25 · see citing works

Stereochemistry of the transesterification step of pancreatic ribonuclease

Eckstein, F., Saenger, W., & Suck, D. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(72)80235-3 · Cited by 25 · see citing works

Kinase Assay Based on Thiophosphorylation and Biotinylation

Jeong, S., & Nikiforov, T. T. (1999) · BioTechniques · doi:10.2144/99276rr01 · Cited by 23 · see citing works

Site-Specific Derivatization of RNA with Photocrosslinkable Groups

Konarska, M. M. (1999) · Methods · doi:10.1006/meth.1999.0753 · Cited by 22 · see citing works

Decoy oligodeoxynucleotide against STAT transcription factors decreases allergic inflammation in a rat asthma model

Lührmann, A., Tschernig, T., von der Leyen, H. E., Hecker, M., Pabst, R., & Wagner, A. H. (2010) · Experimental Lung Research · doi:10.3109/01902140903144138 · Cited by 22 · see citing works

Exploring the Effect of Sequence Length and Composition on Allele-Selective Inhibition of Human Huntingtin Expression by Single-Stranded Silencing RNAs

Hu, J., Liu, J., Yu, D., Aiba, Y., Lee, S., Pendergraff, H. M., Boubaker-Vitre, J., Artates, J. W., Lagier‐Tourenne, C., Lima, W. F., et al. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0476 · Cited by 22 · see citing works

Synthesis, Properties and Application of Nucleic Acids Containing Phosphorothiolate Linkages

Cosstick, R., & Gaynor, J. W. (2008) · Current Organic Chemistry · doi:10.2174/138527208783743769 · Cited by 20 · see citing works

Inhibition of restriction endonuclease hydrolysis by phosphorothioate-containing DNA

Sayers, J. R., Olsen, D. B., & Eckstein, F. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.22.9495 · Cited by 19 · see citing works

Antisense-Mediated Exon Skipping: Networking to Meet Opportunities and to Overcome Challenges

Aartsma-Rus, A. M. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2014.1500 · Cited by 17 · see citing works

Advances in oligonucleotide drug delivery

Roberts, T. C., Langer, R., & Wood, M. J. A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0075-7 · Cited by 2,026 · see citing works

The evolution of commercial drug delivery technologies

Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361 · see citing works

The chemical evolution of oligonucleotide therapies of clinical utility

Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216 · see citing works

Overcoming cellular barriers for RNA therapeutics

Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139 · see citing works

Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells

Hendel, A., Bak, R. O., Clark, J. T., Kennedy, A. B., Ryan, D. E., Roy, S., Steinfeld, I., Lunstad, B. D., Kaiser, R. J., Wilkens, A. B., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3290 · Cited by 1,090 · see citing works

siRNA versus miRNA as therapeutics for gene silencing

Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081 · see citing works

The delivery of therapeutic oligonucleotides

Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 863 · see citing works

RNA-based therapeutics: an overview and prospectus

Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05075-2 · Cited by 658 · see citing works

Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs

Shen, X., & Corey, D. R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1239 · Cited by 639 · see citing works

Lipids and Lipid Derivatives for RNA Delivery

Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 638 · see citing works

Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development

Dhuri, K., Bechtold, C., Quijano, E., Pham, H. T. T., Gupta, A., Vikram, A., & Bahal, R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9062004 · Cited by 554 · see citing works

Splice-switching antisense oligonucleotides as therapeutic drugs

Havens, M. A., & Hastings, M. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw533 · Cited by 541 · see citing works

The Medicinal Chemistry of Therapeutic Oligonucleotides

Wan, W. B., & Seth, P. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00551 · Cited by 435 · see citing works

Aptamer chemistry

Röthlisberger, P., & Hollenstein, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.007 · Cited by 415 · see citing works

Advances in genome editing through control of DNA repair pathways

Yeh, C. D., Richardson, C. D., & Corn, J. E. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0425-z · Cited by 405 · see citing works

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

Hammond, S. M., Aartsma-Rus, A. M., Alves, S., Borgos, S. E., Buijsen, R. A. M., Collin, R. W. J., Covello, G., Denti, M. A., Desviat, L. R., Echevarría, L., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013243 · Cited by 395 · see citing works

Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides

Iwamoto, N., Butler, D. C. D., Svrzikapa, N., Mohapatra, S., Zlatev, I., Sah, D. W. Y., Meena, M., Standley, S. M., Lu, G., Apponi, L. H., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3948 · Cited by 382 · see citing works

Phosphorothioate modified oligonucleotide–protein interactions

Crooke, S. T., Vickers, T. A., & Liang, X.-H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa299 · Cited by 372 · see citing works

Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy

Garland, K. M., Sheehy, T. L., & Wilson, J. T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00750 · Cited by 368 · see citing works

RNA modifications in physiology and disease: towards clinical applications

Delaunay, S., Helm, M., & Frye, M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00645-2 · Cited by 358 · see citing works

Advancement of the emerging field of RNA nanotechnology

Jasinski, D., Haque, F., Binzel, D. W., & Guo, P. (2017) · ACS Nano · doi:10.1021/acsnano.6b05737 · Cited by 352 · see citing works

Recent progress in non-native nucleic acid modifications

McKenzie, L. K., El-Khoury, R., Thorpe, J. D., Damha, M. J., & Hollenstein, M. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01430c · Cited by 300 · see citing works

Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics

Lorenzer, C., Dirin, M., Winkler, A.-M., Baumann, V., & Winkler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.003 · Cited by 284 · see citing works

Therapeutic targeting of non-coding RNAs in cancer

Slabý, O., Laga, R., & Sedláček, O. (2017) · Biochemical Journal · doi:10.1042/bcj20170079 · Cited by 248 · see citing works

RNAs containing modified nucleotides fail to trigger RIG-I conformational changes for innate immune signaling

Durbin, A. F., Wang, C., Marcotrigiano, J., & Gehrke, L. (2016) · mBio · doi:10.1128/mbio.00833-16 · Cited by 238 · see citing works

Locked nucleic acid: modality, diversity, and drug discovery

Hagedorn, P., Persson, R., Funder, E. D., Albæk, N., Diemer, S. L., Hansen, D. J., Møller, M. R., Papargyri, N., Christiansen, H., Hansen, B. R., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.09.018 · Cited by 237 · see citing works

A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system

Alterman, J. F., Godinho, B. M. D. C., Hassler, M. R., Ferguson, C. M., Echeverria, D., Sapp, E., Haraszti, R. A., Coles, A. H., Conroy, F., Miller, R., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0205-0 · Cited by 227 · see citing works

Current Development of siRNA Bioconjugates: From Research to the Clinic

Chernikov, I. V., Vlassov, V. V., & Chernolovskaya, E. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00444 · Cited by 216 · see citing works

DNA Nanostructures: Current Challenges and Opportunities for Cellular Delivery

Lacroix, A., & Sleiman, H. F. (2021) · ACS Nano · doi:10.1021/acsnano.0c06136 · Cited by 194 · see citing works

Synthetic CRISPR RNA-Cas9–guided genome editing in human cells

Rahdar, M., McMahon, M. A., Prakash, T. P., Swayze, E. E., Bennett, C. F., & Cleveland, D. W. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520883112 · Cited by 183 · see citing works

Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles

Bost, J., Barriga, H. M. G., Holme, M. N., Gallud, A., Maugeri, M., Gupta, D., Lehto, T., Valadi, H., Esbjörner, E. K., Stevens, M. M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c05099 · Cited by 187 · see citing works

Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo

Hassler, M. R., Turanov, A. A., Alterman, J. F., Haraszti, R. A., Coles, A. H., Osborn, M. F., Echeverria, D., Nikan, M., Salomon, W. E., Roux, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky037 · Cited by 181 · see citing works

Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide

Tran, H., Moazami, M. P., Yang, H., McKenna-Yasek, D., Douthwright, C. L., Pinto, C., Metterville, J., Shin, M., Sanil, N., Dooley, C., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01557-6 · Cited by 174 · see citing works

Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver

Miller, C. M., Donner, A. J., Blank, E. K., Egger, A. W., Kellar, B. M., Østergaard, M. E., Seth, P. P., & Harris, E. N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw112 · Cited by 171 · see citing works

Nucleic‐Acid Structures as Intracellular Probes for Live Cells

Samanta, D., Ebrahimi, S. B., & Mirkin, C. A. (2019) · Advanced Materials · doi:10.1002/adma.201901743 · Cited by 156 · see citing works

Opportunities and challenges for antisense oligonucleotide therapies

Kuijper, E. C., Bergsma, A. J., Pijnappel, W. W. M. P., & Aartsma-Rus, A. M. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12251 · Cited by 156 · see citing works

Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications

Harun‐Ur‐Rashid, M., Jahan, I., Foyez, T., & Imran, A. B. (2023) · Micromachines · doi:10.3390/mi14091786 · Cited by 159 · see citing works

miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review

Martino, M. T. D., Arbitrio, M., Caracciolo, D., Cordua, A., Cuomo, O., Grillone, K., Riillo, C., Caridà, G., Scionti, F., Labanca, C., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.005 · Cited by 153 · see citing works

Editorial focus: understanding off-target effects as the key to successful RNAi therapy

Bartoszewski, R., & Sikorski, A. F. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0196-3 · Cited by 150 · see citing works

Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay

Gaus, H. J., Gupta, R., Chappell, A. E., Østergaard, M. E., Swayze, E. E., & Seth, P. P. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1260 · Cited by 144 · see citing works

Characterization of therapeutic oligonucleotides by liquid chromatography

Goyon, A., Yehl, P., & Zhang, K. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113105 · Cited by 142 · see citing works

Improving siRNA Delivery <i>In Vivo</i> Through Lipid Conjugation

Osborn, M. F., & Khvorova, A. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0725 · Cited by 137 · see citing works

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides

Anderson, B. A., Freestone, G. C., Low, A., Hoyos, C. L. D., Drury, W. J., Østergaard, M. E., Migawa, M. T., Fazio, M., Wan, W. B., Berdeja, A., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab718 · Cited by 135 · see citing works

The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives

Walgrave, H., Zhou, L., Strooper, B. D., & Salta, E. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00496-7 · Cited by 132 · see citing works

DNA phosphorothioate modification—a new multi-functional epigenetic system in bacteria

Wang, L., Jiang, S., Deng, Z., Dedon, P. C., & Chen, S. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy036 · Cited by 126 · see citing works

The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents

Crooke, S. T., Seth, P. P., Vickers, T. A., & Liang, X. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c04928 · Cited by 127 · see citing works

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease

Fusco, D. D., Dinallo, V., Marafini, I., Figliuzzi, M. M., Romano, B., & Monteleone, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00305 · Cited by 123 · see citing works

Transcription factor decoy technology: A therapeutic update

Hecker, M., & Wagner, A. H. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.122 · Cited by 116 · see citing works

Oligonucleotide Therapeutics: Chemistry, Delivery and Clinical Progress

Sharma, V. K., & Watts, J. K. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.144 · Cited by 109 · see citing works

Selective tissue targeting of synthetic nucleic acid drugs

Seth, P. P., Tanowitz, M., & Bennett, C. F. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125228 · Cited by 109 · see citing works

Nucleic acid drug vectors for diagnosis and treatment of brain diseases

Lü, Z., Shen, J., Yang, H. J., Wang, J., Zhao, R., Zhang, T.-L., Guo, J. R., & Zhang, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01298-z · Cited by 108 · see citing works

Chemical methods for the modification of RNA

Flamme, M., McKenzie, L. K., Sarac, I., & Hollenstein, M. (2019) · Methods · doi:10.1016/j.ymeth.2019.03.018 · Cited by 103 · see citing works

Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates

Østergaard, M. E., Jackson, M., Low, A., Chappell, A. E., Lee, R. G., Peralta, R. Q., Yu, J., Kinberger, G. A., Dan, A., Carty, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz360 · Cited by 101 · see citing works

Stressing the Role of DNA as a Drug Carrier: Synthesis of DNA–Drug Conjugates through Grafting Chemotherapeutics onto Phosphorothioate Oligonucleotides

Guo, Y., Zhang, J., Ding, F., Pan, G., Li, J., Feng, J. C., Zhu, X., & Zhang, C. (2019) · Advanced Materials · doi:10.1002/adma.201807533 · Cited by 100 · see citing works

Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach

Haghighi, E., Abolmaali, S. S., Dehshahri, A., Shaegh, S. A. M., Azarpira, N., & Tamaddon, A. M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02972-w · Cited by 110 · see citing works

Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides

Østergaard, M. E., Hoyos, C. L. D., Wan, W. B., Shen, W., Low, A., Berdeja, A., Vasquez, G., Murray, S., Migawa, M. T., Liang, X., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa031 · Cited by 99 · see citing works

Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for Proteins

Hyjek‐Składanowska, M., Vickers, T. A., Napiórkowska-Gromadzka, A., Anderson, B. A., Tanowitz, M., Crooke, S. T., Liang, X., Seth, P. P., & Nowotny, M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b13524 · Cited by 99 · see citing works

Chemistry of Peptide-Oligonucleotide Conjugates: A Review

Klabenkova, K., Фокина, А. А., & Stetsenko, D. A. (2021) · Molecules · doi:10.3390/molecules26175420 · Cited by 100 · see citing works

Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias

Katzmann, J. L., Packard, C. J., Chapman, M. J., Katzmann, I., & Laufs, U. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.070 · Cited by 99 · see citing works

An intranasal ASO therapeutic targeting SARS-CoV-2

Zhu, C., Lee, J. Y., Woo, J. Z., Xu, L., Wrynla, X. H., Yamashiro, L. H., Ji, F., Biering, S. B., Dis, E. S. V., Gonzãlez, F., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32216-0 · Cited by 97 · see citing works

An Update: Enzymatic Synthesis for Industrial Applications

Bayer, T., Wu, S., Šnajdrová, R., Baldenius, K., & Bornscheuer, U. T. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505976 · Cited by 98 · see citing works

Chemical Synthesis and Biological Application of Modified Oligonucleotides

Glazier, D. A., Liao, J., Roberts, B. L., Li, X., Yang, K., Stevens, C. M., & Tang, W. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00060 · Cited by 91 · see citing works

Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing

Kelley, M. L., Strezoska, Ž., He, K., Vermeulen, A., & Smith, A. V. B. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.06.011 · Cited by 89 · see citing works

Advances in therapeutic bacterial antisense biotechnology

Hegarty, J. P., & Stewart, D. B. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8671-0 · Cited by 91 · see citing works

Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo

Jahns, H., Taneja, N., Willoughby, J. L. S., Akabane‐Nakata, M., Brown, C. R., Nguyen, T. M., Bisbe, A., Matsuda, S., Hettinger, M., Manoharan, R. M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab544 · Cited by 91 · see citing works

Occurrence, evolution, and functions of DNA phosphorothioate epigenetics in bacteria

Tong, T., Chen, S., Wang, L., Tang, Y., Ryu, J. Y., Jiang, S., Wu, X., Chen, C., Luo, J., Deng, Z., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1721916115 · Cited by 89 · see citing works

Nucleic Acid Drugs—Current Status, Issues, and Expectations for Exosomes

Yamada, Y. (2021) · Cancers · doi:10.3390/cancers13195002 · Cited by 89 · see citing works

Chemically Modified Cpf1-CRISPR RNAs Mediate Efficient Genome Editing in Mammalian Cells

McMahon, M. A., Prakash, T. P., Cleveland, D. W., Bennett, C. F., & Rahdar, M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.031 · Cited by 87 · see citing works

From “Cellular” RNA to “Smart” RNA: Multiple Roles of RNA in Genome Stability and Beyond

Michelini, F., Jalihal, A. P., Francia, S., Meers, C., Neeb, Z. T., Rossiello, F., Gioia, U., Aguado, J., Jones-Weinert, C., Luke, B., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00487 · Cited by 85 · see citing works

The Toolbox for Modified Aptamers

Lapa, S. A., Chudinov, A. V., & Timofeev, E. N. (2015) · Molecular Biotechnology · doi:10.1007/s12033-015-9907-9 · Cited by 84 · see citing works

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases

Holm, A., Hansen, S. N., Klitgaard, H., & Kauppinen, S. (2022) · RNA Biology · doi:10.1080/15476286.2022.2066334 · Cited by 83 · see citing works

Development of Phosphorothioate DNA and DNA Thioaptamers

Volk, D. E., & Lokesh, G. L.-R. (2017) · Biomedicines · doi:10.3390/biomedicines5030041 · Cited by 83 · see citing works

Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment

Gait, M. J., Arzumanov, A. A., McClorey, G., Godfrey, C., Betts, C., Hammond, S. M., & Wood, M. J. A. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0747 · Cited by 83 · see citing works

Engineering Gene Therapy: Advances and Barriers

Shahryari, A., Burtscher, I., Nazari, Z., & Lickert, H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100040 · Cited by 84 · see citing works

TGFβ signaling pathways in human health and disease

Chen, P., Qin, L., & Simons, M. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1113061 · Cited by 84 · see citing works

Mitigating off‐target effects of small RNAs: conventional approaches, network theory and artificial intelligence

Bereczki, Z., Benczik, B., Balogh, O. M., Marton, S., Puhl, E., Pétervári, M., Váczy‐Földi, M., Papp, Z. T., Makkos, A., Glass, K., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17302 · Cited by 82 · see citing works

A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells

Castanotto, D., Lin, M., Kowolik, C. M., Wang, L., Ren, X., Soifer, H. S., Koch, T., Hansen, B. R., Oerum, H., Armstrong, B., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv964 · Cited by 82 · see citing works

Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models

Liu, Y., Dodart, J., Tran, H., Berkovitch, S. S., Braun, M. C., Byrne, M., Durbin, A. F., Hu, X. S., Iwamoto, N., Jang, H. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21112-8 · Cited by 81 · see citing works

The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma

Wong, H. K., Fatimy, R. E., Onodera, C. S., Wei, Z., Yi, M., Mohan, A., Gowrisankaran, S., Karmali, P. P., Marcusson, E. G., Wakimoto, H., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.72 · Cited by 80 · see citing works

STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers

Moreira, D., Adamus, T., Zhao, X., Su, Y.-L., Zhang, Z., White, S. V., Swiderski, P., Lu, X., DePinho, R. A., Pal, S. K., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1277 · Cited by 80 · see citing works

Using Genome Sequence to Enable the Design of Medicines and Chemical Probes

Angelbello, A. J., Chen, J. L., Childs‐Disney, J. L., Zhang, P., Wang, Z.-F., & Disney, M. D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00504 · Cited by 80 · see citing works

From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies

Adachi, H., Hengesbach, M., Yu, Y., & Morais, P. (2021) · Biomedicines · doi:10.3390/biomedicines9050550 · Cited by 80 · see citing works

Nucleic Acids and Their Analogues for Biomedical Applications

Wang, F., Li, P., Chu, H. C., & Lo, P. K. (2022) · Biosensors · doi:10.3390/bios12020093 · Cited by 81 · see citing works

Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells

Arnold, A. E., Malek-Adamian, E., Le, P. U., Meng, A., Martínez‐Montero, S., Petrecca, K., Damha, M. J., & Shoichet, M. S. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.004 · Cited by 80 · see citing works

Advances in intracellular delivery through supramolecular self-assembly of oligonucleotides and peptides

Kim, J., Ashwanikumar, N., Patel, S., & Sahay, G. (2019) · Theranostics · doi:10.7150/thno.33921 · Cited by 78 · see citing works

Modified internucleoside linkages for nuclease-resistant oligonucleotides

Clavé, G., Reverte, M., Vasseur, J., & Smietana, M. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00136h · Cited by 76 · see citing works

Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases

Chen, S., Heendeniya, S. N., Le, B. T., Rahimizadeh, K., Rabiee, N., Zahra, Q. U. A., & Veedu, R. N. (2024) · BioDrugs · doi:10.1007/s40259-024-00644-7 · Cited by 76 · see citing works

Oligonucleotides: Current Trends and Innovative Applications in the Synthesis, Characterization, and Purification

Catani, M., Luca, C. D., Alcântara, J. M. G., Manfredini, N., Perrone, D., Marchesi, E., Weldon, R., Müller‐Späth, T., Cavazzini, A., Morbidelli, M., et al. (2020) · Biotechnology Journal · doi:10.1002/biot.201900226 · Cited by 75 · see citing works

Strategies to target long non-coding RNAs in cancer treatment: progress and challenges

Dizaji, B. F. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00074-4 · Cited by 76 · see citing works

Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles

Biscans, A., Caiazzi, J., McHugh, N., Hariharan, V. N., Muhuri, M., & Khvorova, A. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.023 · Cited by 75 · see citing works

Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS

Pachamuthu, K., Liu, Y., Aduda, V., Akare, S., Alam, R., Andreucci, A., Boulay, D., Bowman, K., Byrne, M., Cannon, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac037 · Cited by 73 · see citing works

Bottlebrush-architectured poly(ethylene glycol) as an efficient vector for RNA interference in vivo

Wang, D., Lin, J., Jia, F., Tan, X., Wang, Y., Sun, X., Cao, X., Che, F., Lü, H., Gao, X., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav9322 · Cited by 75 · see citing works

Recent advances in polymeric materials for the delivery of RNA therapeutics

Ulkoski, D., Bak, A., Wilson, J. T., & Krishnamurthy, V. R. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1663822 · Cited by 74 · see citing works

The role of miR-214 in cardiovascular diseases

Zhao, Y., Ponnusamy, M., Zhang, L. J., Zhang, Y., Liu, C., Yu, W., Wang, K., & Li, P. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.009 · Cited by 72 · see citing works

Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency

Patutina, O., Miroshnichenko, S. K., Васильевна, С. А., Savin, I. A., Gladkikh, D. V., Burakova, E. A., Фокина, А. А., Maslov, M. A., Shmendel, E. V., Wood, M. J. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2016158117 · Cited by 72 · see citing works

Molecular mechanism of diabetic cardiomyopathy and modulation of microRNA function by synthetic oligonucleotides

Ghosh, N., & Katare, R. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0684-1 · Cited by 71 · see citing works

Advances in siRNA therapeutics and synergistic effect on siRNA activity using emerging dual ribose modifications

Gangopadhyay, S., & Gore, K. R. (2022) · RNA Biology · doi:10.1080/15476286.2022.2052641 · Cited by 71 · see citing works

Agonists and Inhibitors of the cGAS-STING Pathway

Yu, X., Cai, L., Yao, J., Li, C., & Wang, X. (2024) · Molecules · doi:10.3390/molecules29133121 · Cited by 75 · see citing works

A critical analysis of methods used to investigate the cellular uptake and subcellular localization of RNA therapeutics

Deprey, K. L., Batistatou, N., & Kritzer, J. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa576 · Cited by 68 · see citing works

Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression

Strzelecka, D., Śmietański, M., Sikorski, P. J., Warmiński, M., Kowalska, J., & Jemielity, J. (2020) · RNA · doi:10.1261/rna.077099.120 · Cited by 67 · see citing works

Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver

Miller, C. M., Tanowitz, M., Donner, A. J., Prakash, T. P., Swayze, E. E., Harris, E. N., & Seth, P. P. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0709 · Cited by 62 · see citing works

Chemical Modifications of Antisense Oligonucleotides

(2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200900

Oxathiaphospholane Method of the Stereocontrolled Synthesis of Phosphorothioate Analogues of Oligonucleotides

Okruszek, A. (1999) · Springer eBooks · doi:10.1007/978-94-011-4485-8_24 · Cited by 1 · see citing works

In vitro and in vivo biophysical properties of oligonucleotides containing 5'-thio nucleosides

Islam, M. A., Waki, R., Fujisaka, A., Ito, K. R., & Obika, S. (2016) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2016.01055 · Cited by 8 · see citing works

Phosphorothioates

(2008) · Springer eBooks · doi:10.1007/978-1-4020-6754-9_12765